UPB
NASDAQ · Biotechnology
Upstream Bio Inc
$6.31
-0.26 (-3.96%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+291.1% upside
Low Target
$18.50
Average Target
$24.68
High Target
$35.72
Current Price
$6.31
Current
$6.31
$6.31
Target
$24.68
$24.68
$18.50
$24.68 avg
$35.72
Scenario Analysis
Bear Case
$18.50
193.2%
Low target
Base Case
$24.68
+291.1%
Avg target
Bull Case
$35.72
+466.1%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$33.68
-81.3% from high
52-Week Low
$5.85
+7.9% from low
Target vs 52W High
$24.68
-26.7% vs high
Next Earnings Report
Aug 12, 2026
3d
until earnings
EPS Est: $-0.77
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 44 | 64% | $91.45 | -56.0% |